Younger, leaner women tend to see better results from the injection than older or heavier women — but even older or heavier women still benefit more than those who don’t get the treatment.
Scientific Claim
Higher age and body mass index (BMI ≥30 kg/m²) are associated with reduced response to CCH-aaes treatment for buttock cellulite, with the greatest efficacy observed in women under 45 years and with BMI <32 kg/m².
Original Statement
“An inverse relationship between age and CCH-aaes response was observed in those with a body mass index less than 32 kg per m2... Higher response rates were observed in those with a lower age and BMI less than 32 kg per m2... In obese (≥30 kg/m2) women, response rate was 2.5% vs 12.3% in normal-weight women.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The association is derived from post hoc subgroup analyses of an RCT, which can identify trends but not prove causation. The verb 'associated with' is more appropriate than 'causes reduced response'.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized Controlled TrialLevel 1bCausal effect of BMI and age on CCH-aaes response, independent of confounding.
Causal effect of BMI and age on CCH-aaes response, independent of confounding.
What This Would Prove
Causal effect of BMI and age on CCH-aaes response, independent of confounding.
Ideal Study Design
A double-blind RCT of 800 adult women with moderate-to-severe buttock cellulite, stratified by age (<45 vs ≥45) and BMI (<32 vs ≥32 kg/m²), randomized to CCH-aaes or placebo, with primary endpoint being ≥2-level composite response at Day 71, powered for interaction effects.
Limitation: Ethically and practically difficult to randomize by age/BMI; may not reflect real-world distribution.
Prospective Cohort StudyLevel 2bLong-term association between age/BMI and treatment response in real-world settings.
Long-term association between age/BMI and treatment response in real-world settings.
What This Would Prove
Long-term association between age/BMI and treatment response in real-world settings.
Ideal Study Design
A prospective cohort study of 1000 women treated with CCH-aaes, stratified by baseline age and BMI, measuring composite response at 71 days and 12 months, adjusting for confounders (skin laxity, activity level, hormonal status).
Limitation: Cannot prove causation; residual confounding likely.
Case-Control StudyLevel 3bAssociation between age/BMI and non-response to CCH-aaes.
Association between age/BMI and non-response to CCH-aaes.
What This Would Prove
Association between age/BMI and non-response to CCH-aaes.
Ideal Study Design
A case-control study comparing 150 women with ≥2-level response to 150 non-responders, matched for baseline severity, and comparing age and BMI distributions, adjusting for skin type and comorbidities.
Limitation: Prone to selection bias; cannot establish temporal sequence.
Cross-Sectional SurveyLevel 4Correlation between age/BMI and perceived treatment success in a population sample.
Correlation between age/BMI and perceived treatment success in a population sample.
What This Would Prove
Correlation between age/BMI and perceived treatment success in a population sample.
Ideal Study Design
A cross-sectional survey of 1000 women who received CCH-aaes, asking for age, BMI, and self-reported improvement, with photographic validation by blinded assessors.
Limitation: Cannot establish causation or directionality; subject to recall bias.
In Vitro StudyLevel 5Biological mechanism linking age/BMI to reduced collagenase efficacy (e.g., altered collagen structure, fibrosis).
Biological mechanism linking age/BMI to reduced collagenase efficacy (e.g., altered collagen structure, fibrosis).
What This Would Prove
Biological mechanism linking age/BMI to reduced collagenase efficacy (e.g., altered collagen structure, fibrosis).
Ideal Study Design
An in vitro study comparing collagen degradation by CCH-aaes in dermal biopsies from young/lean vs older/obese women, measuring collagen density, cross-linking, and enzymatic kinetics.
Limitation: Cannot replicate systemic or tissue-level interactions in vivo.
Evidence from Studies
Supporting (1)
Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials
The study found that younger women with lower body weight responded better to the cellulite treatment, which matches the claim that older women and those with higher BMI don’t respond as well.